GILEAD SCIENCES, INC. is 35.7x more valuable than Twist Bioscience Corp by market capitalization ($150.83 B vs $4.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TWST | GILD |
|---|---|---|
| Market cap | $4.22 B | $150.83 B |
| US-listed rank | #1523 | #99 |
| Revenue (latest FY) | $376.57M | $29.44B |
| Net income (latest FY) | -$77.67M | $8.51B |
| Net margin | -20.6% | 28.9% |
| P/E (trailing FY) | - | 17.7 |
| SEC filings | 1,496 | 981 |
GILEAD SCIENCES, INC. is 35.7x more valuable than Twist Bioscience Corp by market capitalization ($150.83 B vs $4.22 B).
In their latest fiscal years, Twist Bioscience Corp reported $376.57M in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: Twist Bioscience Corp and GILEAD SCIENCES, INC., or browse the full rankings.